000 | 01363 a2200397 4500 | ||
---|---|---|---|
005 | 20250516052658.0 | ||
264 | 0 | _c20120126 | |
008 | 201201s 0 0 eng d | ||
022 | _a1536-3694 | ||
024 | 7 |
_a10.1097/FTD.0b013e3182281975 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBarnes, Allan J | |
245 | 0 | 0 |
_aMDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration. _h[electronic resource] |
260 |
_bTherapeutic drug monitoring _cOct 2011 |
||
300 |
_a602-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aN-Methyl-3,4-methylenedioxyamphetamine _xadministration & dosage |
650 | 0 | 4 |
_aSaliva _xchemistry |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aScheidweiler, Karl B | |
700 | 1 | _aKolbrich-Spargo, Erin A | |
700 | 1 | _aGorelick, David A | |
700 | 1 | _aGoodwin, Robert S | |
700 | 1 | _aHuestis, Marilyn A | |
773 | 0 |
_tTherapeutic drug monitoring _gvol. 33 _gno. 5 _gp. 602-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/FTD.0b013e3182281975 _zAvailable from publisher's website |
999 |
_c21103403 _d21103403 |